Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Lannett's abbreviated new drug application (ANDA) of Loxapine Capsules, 5mg, 10mg, 25mg and 50mg.
Subscribe to our email newsletter
Lannett’s Loxapine Capsules, 5mg, 10mg, 25mg and 50mg are the generic version of Watson Pharmaceuticals’ Loxitane Capsules, 5mg, 10mg, 25mg and 50mg.
The company expects to start supplying the product soon.
Lannett president and CEO Arthur Bedrosian said they have now received five product approvals from the FDA over the last three months.